Inhibition of steroidogenesis in cultured Leydig tumor cells by 22-amino-23,24-bisnor-5-cholen-3 beta-O1 and (20R) 20-phenyl-5-pregnene-3 beta,20-diol.

Using the cholesterol side-chain cleavage enzyme purified from bovine adrenals, we have previously shown that 22-amino-23,24-bisnor-5-cholen-3-beta-ol (22-ABC) and (20R) 20-phenyl-5-pregnene-3 beta, 20 diol (20-PPD) are potent competitive inhibitors of this enzyme. The studies presented herein were designed to characterize the effects of these new inhibitors on steroid production by intact cells. Using cultured Leydig tumor cells, we compared the effects of 22-ABC, 20-PPD, and aminoglutethimide (a well-known inhibitor of the cholesterol side-chain cleavage enzyme) on hormone-stimulated steroidogenesis. Our results show that these compounds inhibit steroid production in a dose-dependent manner and that 20-PPD and 22-ABC are about 100 and 4 times more active, respectively, than aminoglutethimide. In these cells, the inhibitory effects of the new compounds seem to be localized exclusively at the conversion of cholesterol to pregnenolone.
AuthorsM Ascoli, D A Freeman, J J Sheets, L E Vickery
JournalEndocrinology (Endocrinology) Vol. 113 Issue 1 Pg. 127-32 (Jul 1983) ISSN: 0013-7227 [Print] UNITED STATES
PMID6683151 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • 20-phenyl-5-pregnene-3 beta,20-diol
  • Chorionic Gonadotropin
  • Pregnenes
  • Aminoglutethimide
  • Progesterone
  • 22-aminocholesterol
  • Pregnenolone
  • Cytochrome P-450 Enzyme System
  • Cholesterol
  • Aminoglutethimide (pharmacology)
  • Animals
  • Cattle
  • Cholesterol (analogs & derivatives, pharmacology)
  • Chorionic Gonadotropin (pharmacology)
  • Cytochrome P-450 Enzyme System (metabolism)
  • Dose-Response Relationship, Drug
  • Leydig Cell Tumor (metabolism)
  • Male
  • Pregnenes (pharmacology)
  • Pregnenolone (metabolism)
  • Progesterone (metabolism)
  • Testicular Neoplasms (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: